CLINICAL_TRIALS
research
· 2024-10-17
Clinical Trial Update: A Study of KC1036 in Patients with Advanced Thymic Tumors [Phase 2]
Summary
A Phase 2 clinical trial of KC1036 in patients with advanced thymic tumors is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Konruns Pharmaceutical Co., Ltd. | Conditions: Thymic Tumors | Phase 2 | Status: RECRUITING